Therapeutic Communication Training of the Stretcher Bearers on the Patient Anxiety (STRESSCOM)

NCT03849976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-02-03

No results posted yet for this study

Summary

Anxiety is a form of psychic and/or physical discomfort caused by the feeling of the imminence of a danger. It is a frequent perioperative manifestation of patients. Pharmacological premedication is currently used to avoid perioperative anxiety. However, its effect is now controversial and non-drug techniques have been also studied.

The therapeutic communication aims to provide analgesia or anxiolysis to enhance the patient's well-being and to separate the patient from the surrounding reality through the suggestion of positive images with a chosen verbal and nonverbal approach. This prospective, monocentric, comparative, double-blind study aims to evaluate the impact of the training of stretcher-bearers in therapeutic communication on the anxiety of patients who go to the operating room for an endoscopic examination under general anaesthesia.Two groups of patients will be compared: In the first group patients will be accompanied to the operating room by a stretcher-bearer trained in therapeutic communication, in the second group patients will be accompanied by a stretcher bearer without this specific training.

Conditions

Interventions

BEHAVIORAL

Therapeutic communication

Patients will be accompanied to the operating room by a stretcher bearer trained in therapeutic communication

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER
  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Christophe Canevet · Lille Catholic University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-25
Primary Completion
2019-12-17
Completion
2019-12-17

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849976 on ClinicalTrials.gov